Education
About Us
Working with TipRanks
Follow Us
Richard Steinhart Insider Profile
11 Followers
Richard Steinhart, Director at Atossa Therapeutics, holds 6.64K shares in Bioxcel Therapeutics (Ticker: BTAI), holds 9.50K shares in Actinium Pharmaceuticals (Ticker: ATNM), holds 0.00 shares in Atossa Therapeutics (Ticker: ATOS).
Richard Steinhart Atossa Therapeutics (ATOS)Director
Atossa Therapeutics (ATOS)
Director
Ranked #26,155 out of 106,487 Corporate Insiders
Profitable Transactions
3 out of 4 Profitable Transactions
Average Return
+15.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Richard Steinhart holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Nov 30, 2018 - Nov 30, 2019
Return:+28.70%
The most profitable trade made by Richard Steinhart
Richard Steinhart's Trading History
Atossa Therapeutics
May 08, 2014
Director
Uninformative Sell
―
$0.00
Bioxcel Therapeutics
Mar 16, 2026
CFO
Uninformative Buy
101.32
$10.23K
Actinium Pharmaceuticals
Mar 08, 2018
Director
Uninformative Buy
3.50K
$10.54K
Strata Skin Sciences
Aug 08, 2013
CFO
Uninformative Buy
―
$6.88K
TG Therapeutics
―
Director
―
$324.12K
List of latest transactions for each holding click on a transaction to see Richard Steinhart's performance on stock
You May Also Like
Richard Steinhart insider profile FAQ
What is the percentage of profitable transactions made by Richard Steinhart?
The percentage of profitable transactions made by Richard Steinhart is 75%.
What is the average return per transaction made by Richard Steinhart?
The average return per transaction made by Richard Steinhart is 15.50%.
What stocks does Richard Steinhart hold?
Richard Steinhart holds: ATOS, BTAI, ATNM, SSKN, TGTX stocks.
What was Richard Steinhart’s latest transaction?
Richard Steinhart latest transaction was an Uninformative Buy of $101.32.
What was Richard Steinhart's most profitable transaction?
Richard Steinhart’s most profitable transaction was an Informative Buy of BTAI stock on November 30, 2018. The return on the trade was 28.70%.
What is Richard Steinhart's role in Atossa Therapeutics?
Richard Steinhart's role in Atossa Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.